Millennium: The Takeda Oncology Company announced that the Food and Drug Administration (FDA) has approved Velcade (bortezomib) for the treatment of mantle cell lymphoma (MCL) in previously untreated patients.version of Eisai's Dacogen.

Physicians at the Detroit Medical Center have been awarded a unique prize for an unconventional treatment – using bacon to stop an uncontrollable nosebleed in a 4-year-old with Glanzmann thrombasthenia.

Clinical Charts

Make prescribing decisions with our comparative charts and treatment algorithms.